A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes is a research paper published in Kidney International (2023). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Patient-Centered Outcomes Research Institute
Grant: DB-2020C2-20326
National Institutes of Health
Grant: AR 075117
National Institutes of Health
Grant: K01AG068365
National Institutes of Health
Grant: K08AG055670
National Institute on Aging
Grant: R01 AG075335
National Institute on Aging
Grant: RF1AG063381-01
U.S. Food and Drug Administration
Grant: 5U01FD007213
Fields of Study